Reply to Kern, C. The Difficulty of Measuring the Absorption of Scattered Sunlight by H2O and CO2 in Volcanic Plumes: A Comment on Pering, et al. "A Novel and Inexpensive Method for Measuring Volcanic Plume Water Fluxes at High Temporal Resolution", Remote Sens. 2017, 9, 146

We would like to thank our colleague, Christoph Kern, for his comment [1] on our recent paper [2], which provides a valuable adjunct to that published piece [...

Ultraviolet imaging of volcanic plumes: A new paradigm in volcanology

Ultraviolet imaging has been applied in volcanology over the last ten years or so. This provides considerably higher temporal and spatial resolution volcanic gas emission rate data than available previously, enabling the volcanology community to investigate a range of far faster plume degassing processes than achievable hitherto. To date, this has covered rapid oscillations in passive degassing through conduits and lava lakes, as well as puffing and explosions, facilitating exciting connections to be made for the first time between previously rather separate sub-disciplines of volcanology. Firstly, there has been corroboration between geophysical and degassing datasets at ≈1 Hz, expediting more holistic investigations of volcanic source-process behaviour. Secondly, there has been the combination of surface observations of gas release with fluid dynamic models (numerical, mathematical, and laboratory) for gas flow in conduits, in attempts to link subterranean driving flow processes to surface activity types. There has also been considerable research and development concerning the technique itself, covering error analysis and most recently the adaptation of smartphone sensors for this application, to deliver gas fluxes at a significantly lower instrumental price point than possible previously. At this decadal juncture in the application of UV imaging in volcanology, this article provides an overview of what has been achieved to date as well as a forward look to possible future research directions

Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine. A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial

Background: The PRESTO study of non-invasive vagus nerve stimulation (nVNS; gammaCore®) featured key primary and secondary end points recommended by the International Headache Society to provide Class I evidence that for patients with an episodic migraine, nVNS significantly increases the probability of having mild pain or being pain-free 2 h post stimulation. Here, we examined additional data from PRESTO to provide further insights into the practical utility of nVNS by evaluating its ability to consistently deliver clinically meaningful improvements in pain intensity while reducing the need for rescue medication. Methods: Patients recorded pain intensity for treated migraine attacks on a 4-point scale. Data were examined to compare nVNS and sham with regard to the percentage of patients who benefited by at least 1 point in pain intensity. We also assessed the percentage of attacks that required rescue medication and pain-free rates stratified by pain intensity at treatment initiation. Results: A significantly higher percentage of patients who used acute nVNS treatment (n = 120) vs sham (n = 123) reported a ≥ 1-point decrease in pain intensity at 30 min (nVNS, 32.2%; sham, 18.5%; P = 0.020), 60 min (nVNS, 38.8%; sham, 24.0%; P = 0.017), and 120 min (nVNS, 46.8%; sham, 26.2%; P = 0.002) after the first attack. Similar significant results were seen when assessing the benefit in all attacks. The proportion of patients who did not require rescue medication was significantly higher with nVNS than with sham for the first attack (nVNS, 59.3%; sham, 41.9%; P = 0.013) and all attacks (nVNS, 52.3%; sham, 37.3%; P = 0.008). When initial pain intensity was mild, the percentage of patients with no pain after treatment was significantly higher with nVNS than with sham at 60 min (all attacks: nVNS, 37.0%; sham, 21.2%; P = 0.025) and 120 min (first attack: nVNS, 50.0%; sham, 25.0%; P = 0.018; all attacks: nVNS, 46.7%; sham, 30.1%; P = 0.037). Conclusions: This post hoc analysis demonstrated that acute nVNS treatment quickly and consistently reduced pain intensity while decreasing rescue medication use. These clinical benefits provide guidance in the optimal use of nVNS in everyday practice, which can potentially reduce use of acute pharmacologic medications and their associated adverse events. Trial registration: ClinicalTrials.gov identifier: NCT02686034

Elevated CO2 emissions during magmatic-hydrothermal degassing at Awu Volcano, Sangihe Arc, Indonesia

Awu is a remote and little known active volcano of Indonesia located in the northern part of Molucca Sea. It is the northernmost active volcano of the Sangihe arc with 18 eruptions in less than 4 centuries, causing a cumulative death toll of 11,048. Two of these eruptions were classified with a Volcanic Explosivity Index (VEI) of 4. Since 2004, a lava dome has occupied the centre of Awu crater, channelling the fumarolic gas output along the crater wall. A combined Differential Optical Absorption Spectroscopy (DOAS) and Multi-component Gas Analyzer System (Multi-GAS) study highlight a relatively small SO2 flux (13 t/d) sustained by mixed magmatic–hydrothermal emissions made-up of 82 mol.% H2O, 15 mol.% CO2, 2.55 mol.% total S (ST) and 0.02 mol.% H2. The CO2 emission budget, as observed during a short observation period in 2015, corresponds to a daily contribution to the atmosphere of 2600 t/d, representing 1% of the global CO2 emission budget from volcanoes. The gas CO2/ST ratio of 3.7 to 7.9 is at the upper limit of the Indonesian gas range, which is ascribed to (i) some extent of S loss during hydrothermal processing, and perhaps (ii) a C-rich signature of the feeding magmatic gas phase. The source of this high CO2 signature and flux is yet to be fully understood; however, given the peculiar geodynamic context of the region, dominated by the arc-to-arc collision, this may result from either the prolonged heating of the slab and consequent production of carbon-rich fluids, or the recycling of crustal carbon

First In-Situ Measurements of Plume Chemistry at Mount Garet Volcano, Island of Gaua (Vanuatu)

Recent volcanic gas compilations have urged the need to expand in-situ plume measurements to poorly studied, remote volcanic regions. Despite being recognized as one of the main volcanic epicenters on the planet, the Vanuatu arc remains poorly characterized for its subaerial emissions and their chemical imprints. Here, we report on the first plume chemistry data for Mount Garet, on the island of Gaua, one of the few persistent volatile emitters along the Vanuatu arc. Data were collected with a multi-component gas analyzer system (multi-GAS) during a field campaign in December 2018. The average volcanic gas chemistry is characterized by mean molar CO2/SO2, H2O/SO2, H2S/SO2 and H2/SO2 ratios of 0.87, 47.2, 0.13 and 0.01, respectively. Molar proportions in the gas plume are estimated at 95.9 ± 11.6, 1.8 ± 0.5, 2.0 ± 0.01, 0.26 ± 0.02 and 0.06 ± 0.01, for H2O, CO2, SO2, H2S and H2. Using the satellite-based 10-year (2005–2015) averaged SO2 flux of ~434 t d−1 for Mt. Garet, we estimate a total volatile output of about 6482 t d−1 (CO2 ~259 t d−1; H2O ~5758 t d−1; H2S ~30 t d−1; H2 ~0.5 t d−1). This may be representative of a quiescent, yet persistent degassing period at Mt. Garet; whilst, as indicated by SO2 flux reports for the 2009–2010 unrest, emissions can be much higher during eruptive episodes. Our estimated emission rates and gas composition for Mount Garet provide insightful information on volcanic gas signatures in the northernmost part of the Vanuatu Arc Segment. The apparent CO2-poor signature of high-temperature plume degassing at Mount Garet raises questions on the nature of sediments being subducted in this region of the arc and the possible role of the slab as the source of subaerial CO2. In order to better address the dynamics of along-arc volatile recycling, more volcanic gas surveys are needed focusing on northern Vanuatu volcanoes

A SO2 flux study of the Etna volcano 2020–2021 paroxysmal sequences

The persistent open-vent degassing of Mt. Etna is often punctuated by months-long paroxysmal sequences characterized by episodes of violent Strombolian to lava fountaining activity. Understanding these gas-fueled transitions from quiescence to eruption requires routine measurement of gas fluxes. Here, we report SO2 flux measurements, obtained from a permanent UV camera system, collected over a two-year-long period spanning two paroxysmal sequences of Etna’s New South East Crater (NSEC) in December 2020/April 2021 and May/October 2021. In both cases, SO2 flux increased from ≤ 3250 Mg/day during “ordinary” activity to ≥ 4200 Mg/day. We interpret these distinct SO2 degassing regimes in light of seismic and thermal observations and drawing on numerical simulations of sulfur degassing constrained by parental melt sulfur contents in Etna’s hawaiites. We find that initiation of a paroxysmal sequence results from an approximate doubling of the time-averaged rate of magma supply (and degassing) above the sulfur exsolution level (∼150 MPa pressure), to >4 m3/s. This corroborates recent models that argue for the triggering of paroxysmal sequences by escalating supply of volatile-rich magma to a reservoir ∼3–4 km below the summit region. The non-stationary nature of magma flow and volcanic degassing we identify highlights the need for sustained surveillance to characterize long-term atmospheric budgets of volcanic volatiles

First in-situ measurements of plume chemistry at mount garet volcano, island of gaua (Vanuatu)

Recent volcanic gas compilations have urged the need to expand in-situ plume measurements to poorly studied, remote volcanic regions. Despite being recognized as one of the main volcanic epicenters on the planet, the Vanuatu arc remains poorly characterized for its subaerial emissions and their chemical imprints. Here, we report on the first plume chemistry data for Mount Garet, on the island of Gaua, one of the few persistent volatile emitters along the Vanuatu arc. Data were collected with a multi-component gas analyzer system (multi-GAS) during a field campaign in December 2018. The average volcanic gas chemistry is characterized by mean molar CO2 /SO2, H2 O/SO2, H2 S/SO2 and H2 /SO2 ratios of 0.87, 47.2, 0.13 and 0.01, respectively. Molar proportions in the gas plume are estimated at 95.9 ± 11.6, 1.8 ± 0.5, 2.0 ± 0.01, 0.26 ± 0.02 and 0.06 ± 0.01, for H2 O, CO2, SO2, H2 S and H2 . Using the satellite-based 10-year (2005–2015) averaged SO2 flux of ~434 t d−1 for Mt. Garet, we estimate a total volatile output of about 6482 t d−1 (CO2 ~259 t d−1; H2 O ~5758 t d−1; H2 S ~30 t d−1; H2 ~0.5 t d−1 ). This may be representative of a quiescent, yet persistent degassing period at Mt. Garet; whilst, as indicated by SO2 flux reports for the 2009–2010 unrest, emissions can be much higher during eruptive episodes. Our estimated emission rates and gas composition for Mount Garet provide insightful information on volcanic gas signatures in the northernmost part of the Vanuatu Arc Segment. The apparent CO2-poor signature of high-temperature plume degassing at Mount Garet raises questions on the nature of sediments being subducted in this region of the arc and the possible role of the slab as the source of subaerial CO2 . In order to better address the dynamics of along-arc volatile recycling, more volcanic gas surveys are needed focusing on northern Vanuatu volcanoes

Volcanic activity and gas emissions along the South Sandwich Arc

The South Sandwich Volcanic Arc is one of the most remote and enigmatic arcs on Earth. Sporadic observations from rare cloud-free satellite images—and even rarer in situ reports—provide glimpses into a dynamic arc system characterised by persistent gas emissions and frequent eruptive activity. Our understanding of the state of volcanic activity along this arc is incomplete compared to arcs globally. To fill this gap, we present here detailed geological and volcanological observations made during an expedition to the South Sandwich Islands in January 2020. We report the first in situ measurements of gas chemistry, emission rate and carbon isotope composition from along the arc. We show that Mt. Michael on Saunders Island is a persistent source of gas emissions, releasing 145 ± 59 t day−1 SO2 in a plume characterised by a CO2/SO2 molar ratio of 1.8 ± 0.2. Combining this CO2/SO2 ratio with our independent SO2 emission rate measured near simultaneously, we derive a CO2 flux of 179 ± 76 t day−1. Outgassing from low temperature (90–100 °C) fumaroles is pervasive at the active centres of Candlemas and Bellingshausen, with measured gas compositions indicative of interaction between magmatic fluids and hydrothermal systems. Carbon isotope measurements of dilute plume and fumarole gases from along the arc indicate a magmatic δ13C of − 4.5 ± 2.0‰. Interpreted most simply, this result suggests a carbon source dominated by mantle-derived carbon. However, based on a carbon mass balance from sediment core ODP 701, we show that mixing between depleted upper mantle and a subduction component composed of sediment and altered crust is also permissible. We conclude that, although remote, the South Sandwich Volcanic Arc is an ideal tectonic setting in which to explore geochemical processes in a young, developing arc

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients

Background & aims: The fourth dose of anti-SARS-CoV-2 vaccine slightly improved the humoral response among previously seronegative liver transplant (LT) recipients. Mycophenolate (MMF) treatment worsens the vaccination response. This study aimed to evaluate whether temporary MMF interruption might improve the immunogenicity of the fourth anti-SARS-CoV-2 BNT16b2 vaccine dose in nonresponsive LT recipients. Methods: LT recipients negative for anti-spike glycoprotein-specific immunoglobulin G receptor-binding domain (s-RBD) antibodies after the third vaccine dose were enrolled. Anti-SARS-CoV-2 spike-specific T-cell responses were measured before and 2 months following the fourth vaccine dose, and anti-SARS-CoV-2 s-RBD antibodies also 6 months thereafter. MMF was suspended two weeks before and after vaccination. Results: Five LT recipients were enrolled. After a mean of 78 days after vaccination, all patients tested positive for anti-SARS-CoV-2 s-RBD antibodies. The mean antibody titer was 8944 UI/mL. The positive antibody response was maintained during a mean of 193 days of follow-up. Three patients developed a positive T-cell response. Two patients (one positive for T-cell response) developed a self-limited SARS-CoV-2 infection. Conclusions: Suspending MMF prior to the fourth dose of the anti-SARS-CoV-2 mRNA vaccine seems feasible and safe. This procedure could restore vaccine-induced immunogenicity in a large portion of previously nonresponsive LT recipients